Home › NDC Lookup › RxCUI directory › RxCUI 1049167

Pseudoephedrine hydrochloride 60 MG Oral Tablet — RxCUI 1049167

Name: Pseudoephedrine hydrochloride 60 MG Oral Tablet (RxCUI 1049167)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1049167 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1049167

Official namePseudoephedrine hydrochloride 60 MG Oral Tablet

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known aspseudoephedrine HCl 60 MG Oral Tablet

FDA products mapped3

Package NDCs mapped4

Reported Medicaid activity (SDUD)14,013 prescriptions · 23 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pseudoephedrine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It temporarily relieves nasal congestion from the common cold, hay fever or other upper respiratory allergies. Many products also relieve sinus congestion and pressure.
It depends on the product. Regular tablets and softgels are usually taken every 4 to 6 hours, while 12-hour extended-release tablets are taken every 12 hours. Check your box for th...
No. Swallow them whole. Don't divide, crush, chew or dissolve them. Seeing part of the tablet in your stool can happen and is normal.
Can I crush or chew the extended-release tablets?

📖 Read our full Pseudoephedrine guide →

🕸️ Concept Web — How Pseudoephedrine hydrochloride 60 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Pseudoephedrine hydrochloride 60 MG Oral Tablet RxCUI 1049167 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Pseudoephedrine 8896 IN
- Pseudoephedrine hydrochloride 91168 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Sudogest 220077 BN
Dose forms 13

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Pseudoephedrine Oral Tablet 373673 SCDF
- Pseudoephedrine hydrochloride Oral Tablet 2648621 SCDFP
- Pseudoephedrine Oral Product 1163567 SCDG
- Pseudoephedrine Pill 1163568 SCDG
- Pseudoephedrine hydrochloride Oral Product 2662900 SCDGP
- Pseudoephedrine hydrochloride Pill 2662822 SCDGP
- Pseudoephedrine Oral Tablet [Sudogest] 367644 SBDF
- Pseudoephedrine hydrochloride Oral Tablet [Sudogest] 2656726 SBDFP
- +5 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Pseudoephedrine hydrochloride 60 MG 996721 SCDC
- Pseudoephedrine hydrochloride 60 MG Oral Tablet [Sudogest] 1049169 SBD
- Pseudoephedrine hydrochloride 60 MG [Sudogest] 1049168 SBDC

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Pseudoephedrine hydrochloride 60 MG SCDC · 996721
Pseudoephedrine Oral Tablet SCDF · 373673
Pseudoephedrine hydrochloride Oral Tablet SCDFP · 2648621
Pseudoephedrine Oral Product SCDG · 1163567
Pseudoephedrine Pill SCDG · 1163568
Pseudoephedrine hydrochloride Oral Product SCDGP · 2662900
Pseudoephedrine hydrochloride Pill SCDGP · 2662822

Brand-Name Concepts

Pseudoephedrine hydrochloride 60 MG Oral Tablet [Sudogest] SBD · 1049169
Pseudoephedrine hydrochloride 60 MG [Sudogest] SBDC · 1049168
Pseudoephedrine Oral Tablet [Sudogest] SBDF · 367644
Pseudoephedrine hydrochloride Oral Tablet [Sudogest] SBDFP · 2656726
Sudogest Oral Product SBDG · 1183749
Sudogest Pill SBDG · 1183752
Sudogest BN · 220077

📦 FDA Products & Package NDCs

3 products · 4 package NDCs

4 package NDCs map to RxCUI 1049167 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00904-6728-46	30 TABLET in 1 BOTTLE (0904-6728-46)	Pseudoephedrine Hydrochloride	Major Pharmaceuticals	2019-08-29
00904-6728-52	1 BOTTLE in 1 CARTON (0904-6728-52) / 100 TABLET in 1 BOTTL...	Pseudoephedrine Hydrochloride	Major Pharmaceuticals	2019-08-26
00904-6907-06	5 BLISTER PACK in 1 BOX (0904-6907-06) / 10 TABLET in 1 BLI...	Pseudoephedrine Hydrochloride	Major Pharmaceuticals	2019-04-11
50090-4546-01	30 TABLET in 1 BOTTLE (50090-4546-1)	Pseudoephedrine Hydrochloride	A-S Medication Solutions	2019-09-20

Observed labelers: Major Pharmaceuticals (3) · A-S Medication Solutions (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per ea · median

$0.0779

Range $0.0779–$0.0779 · middle 50% $0.0779–$0.0779 · 3 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.